EMA Application withdrawn: Raxone (idebenone) — Santhera Pharmaceuticals (Deutschland) GmbH

View source ↗

Summary

EMA indicates that the application for Raxone (idebenone) has been withdrawn by the applicant.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eye Diseases

Drugs mentioned

• Raxone (idebenone)

Snippet

Status: Application withdrawn. Therapeutic area: Eye Diseases. MAH: Santhera Pharmaceuticals (Deutschland) GmbH. Decision date: 18/01/2013. Orphan medicine